Artiva Biotherapeutics Highlights Updated Sjögren Disease Data
Artiva Biotherapeutics presented updated clinical and safety data for its AlloNK® therapy in Sjögren disease at the 17th International Symposium on Sjögren’s Disease.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Artiva Biotherapeutics highlights updated AlloNK data
Artiva Biotherapeutics said updated AlloNK data in Sjögren disease were presented at the 17th International Symposium on Sjögren’s Disease.